Literature DB >> 27016316

In vitro antiviral activity of adenosine analog NITD008 against tick-borne flaviviruses.

Michael K Lo1, Pei-Yong Shi2, Yen-Liang Chen3, Mike Flint4, Christina F Spiropoulou5.   

Abstract

There are currently no antiviral therapies available for the tick-borne flaviviruses associated with hemorrhagic fevers: Kyasanur Forest disease virus (KFDV), both classical and the Alkhurma hemorrhagic fever virus (AHFV) subtype, and Omsk hemorrhagic fever virus (OHFV). In this brief study, we describe the in vitro antiviral activity of adenosine analog NITD008 against KFDV, AHFV, OHFV, as well as Tick-borne Encephalitis virus (TBEV). Alongside the well-established activity of NITD008 against mosquito-borne flaviviruses, our results have demonstrated the feasibility of identifying nucleoside analog inhibitors that have pan-flavivirus activity. Published by Elsevier B.V.

Entities:  

Keywords:  Antiviral; Flavivirus; NITD008; Nucleoside analog; Tick-borne

Mesh:

Substances:

Year:  2016        PMID: 27016316      PMCID: PMC5096641          DOI: 10.1016/j.antiviral.2016.03.013

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  16 in total

Review 1.  HIV-1 antiretroviral drug therapy.

Authors:  Eric J Arts; Daria J Hazuda
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

2.  Field evaluation of formalin inactivated Kyasanur forest disease virus tissue culture vaccine in three districts of Karnataka state.

Authors:  C N Dandawate; G B Desai; T R Achar; K Banerjee
Journal:  Indian J Med Res       Date:  1994-04       Impact factor: 2.375

3.  Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening.

Authors:  Jonathan S Towner; Jason Paragas; Jason E Dover; Manisha Gupta; Cynthia S Goldsmith; John W Huggins; Stuart T Nichol
Journal:  Virology       Date:  2005-02-05       Impact factor: 3.616

Review 4.  Sofosbuvir for the treatment of hepatitis C virus.

Authors:  Tarik Asselah
Journal:  Expert Opin Pharmacother       Date:  2013-11-30       Impact factor: 3.889

Review 5.  Nucleoside/nucleotide analog inhibitors of hepatitis B virus polymerase: mechanism of action and resistance.

Authors:  Luis Menéndez-Arias; Mar Álvarez; Beatriz Pacheco
Journal:  Curr Opin Virol       Date:  2014-05-09       Impact factor: 7.090

Review 6.  Zoonotic tick-borne flaviviruses.

Authors:  Gerhard Dobler
Journal:  Vet Microbiol       Date:  2009-08-26       Impact factor: 3.293

7.  Combined treatment of adenosine nucleoside inhibitor NITD008 and histone deacetylase inhibitor vorinostat represents an immunotherapy strategy to ameliorate West Nile virus infection.

Authors:  Jacob Nelson; Kelsey Roe; Beverly Orillo; Pei-Yong Shi; Saguna Verma
Journal:  Antiviral Res       Date:  2015-07-29       Impact factor: 5.970

Review 8.  Tick-borne flaviviruses.

Authors:  T S Gritsun; P A Nuttall; Ernest A Gould
Journal:  Adv Virus Res       Date:  2003       Impact factor: 9.937

Review 9.  Kyasanur forest disease.

Authors:  Michael R Holbrook
Journal:  Antiviral Res       Date:  2012-10-27       Impact factor: 5.970

10.  Ancient ancestry of KFDV and AHFV revealed by complete genome analyses of viruses isolated from ticks and mammalian hosts.

Authors:  Kimberly A Dodd; Brian H Bird; Marina L Khristova; César G Albariño; Serena A Carroll; James A Comer; Bobbie R Erickson; Pierre E Rollin; Stuart T Nichol
Journal:  PLoS Negl Trop Dis       Date:  2011-10-04
View more
  20 in total

1.  Nucleoside Analogs with Antiviral Activity against Yellow Fever Virus.

Authors:  Keivan Zandi; Franck Amblard; Sarah Amichai; Leda Bassit; Sijia Tao; Yong Jiang; Longhu Zhou; Olivia Ollinger Russell; Seema Mengshetti; Raymond F Schinazi
Journal:  Antimicrob Agents Chemother       Date:  2019-08-23       Impact factor: 5.191

2.  PARP12 suppresses Zika virus infection through PARP-dependent degradation of NS1 and NS3 viral proteins.

Authors:  Lili Li; Hui Zhao; Ping Liu; Chunfeng Li; Natalie Quanquin; Xue Ji; Nina Sun; Peishuang Du; Cheng-Feng Qin; Ning Lu; Genhong Cheng
Journal:  Sci Signal       Date:  2018-06-19       Impact factor: 8.192

3.  Antiviral Candidates for Treating Hepatitis E Virus Infection.

Authors:  Natalie E Netzler; Daniel Enosi Tuipulotu; Subhash G Vasudevan; Jason M Mackenzie; Peter A White
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

4.  Trans Complementation of Replication-defective Omsk Hemorrhagic Fever Virus for Antiviral Study.

Authors:  Qiuyan Zhang; Na Li; Chenglin Deng; Zherui Zhang; Xiaodan Li; Kentaro Yoshii; Hanqing Ye; Bo Zhang
Journal:  Virol Sin       Date:  2019-04-04       Impact factor: 4.327

Review 5.  Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond.

Authors:  Veaceslav Boldescu; Mira A M Behnam; Nikos Vasilakis; Christian D Klein
Journal:  Nat Rev Drug Discov       Date:  2017-05-05       Impact factor: 84.694

6.  Broad-Spectrum Antiviral Activity of 3'-Deoxy-3'-Fluoroadenosine against Emerging Flaviviruses.

Authors:  Luděk Eyer; Pavel Svoboda; Jan Balvan; Tomáš Vičar; Matina Raudenská; Michal Štefánik; Jan Haviernik; Ivana Huvarová; Petra Straková; Ivo Rudolf; Zdeněk Hubálek; Katherine Seley-Radtke; Erik de Clercq; Daniel Růžek
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

Review 7.  Tick-Borne Flaviviruses, with a Focus on Powassan Virus.

Authors:  Gábor Kemenesi; Krisztián Bányai
Journal:  Clin Microbiol Rev       Date:  2018-12-12       Impact factor: 26.132

8.  An Infectious cDNA Clone of Zika Virus to Study Viral Virulence, Mosquito Transmission, and Antiviral Inhibitors.

Authors:  Chao Shan; Xuping Xie; Antonio E Muruato; Shannan L Rossi; Christopher M Roundy; Sasha R Azar; Yujiao Yang; Robert B Tesh; Nigel Bourne; Alan D Barrett; Nikos Vasilakis; Scott C Weaver; Pei-Yong Shi
Journal:  Cell Host Microbe       Date:  2016-05-16       Impact factor: 21.023

Review 9.  The Use of Ex Vivo Organ Cultures in Tick-Borne Virus Research.

Authors:  Jeffrey M Grabowski; Danielle K Offerdahl; Marshall E Bloom
Journal:  ACS Infect Dis       Date:  2018-02-23       Impact factor: 5.084

10.  Generation and Application of a Luciferase Reporter Virus Based on Yellow Fever Virus 17D.

Authors:  Dan Li; Jing-Long Ye; Zhong-Yu Liu
Journal:  Virol Sin       Date:  2021-08-03       Impact factor: 6.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.